首页>
外国专利>
H3K27 DEMETHYLASE INHIBITORS IN PEDIATRIC AND JUVENILE OSTEOPOROSIS
H3K27 DEMETHYLASE INHIBITORS IN PEDIATRIC AND JUVENILE OSTEOPOROSIS
展开▼
机译:H3K27脱甲基酶抑制剂在儿童和青少年骨质疏松症中的作用
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention provides methods for manipulating epigenetic factors to treat pediatric or juvenile osteoporosis. Specifically, the present invention provides methods for the application of H3K27 demethylase inhibitors in pediatric or juvenile subjects with osteoporosis. Thus, the present invention provides methods of administration of the H3K27 demethylase inhibitor, GSK-J4, to pediatric or juvenile subjects to effectively inhibit primary and secondary pediatric osteoporosis, especially for long-term glucocorticoid treated patients (juvenile rheumatoid disorders, Crohn's disease, nephrotic syndrome, and Duchenne muscular dystrophy) and patients who have compromised mobility (cerebral palsy, Rett syndrome, Duchenne muscular dystrophy, spina bifida, and spinal muscular atrophy).
展开▼